Regulations.gov document
Exhibit 5 - "Guidance for Industry Q3A (R2) Impurities in New Drug Products, Revision 2…
Supporting & Related Material · FDA-2009-P-0289 · posted Jun 29, 2009
Key facts
| Document ID | FDA-2009-P-0289-0005 |
|---|---|
| Title | Exhibit 5 - "Guidance for Industry Q3A (R2) Impurities in New Drug Products, Revision 2, July 2006" - [Reckitt Benckiser Pharmaceuticals Inc. (RBP) - Citizen Petition] re FDA-2009-P-0289-0001 |
| Document type | Supporting & Related Material |
| Subtype | CP-Citizen Petition (Supporting & Related Materials) |
| Agency | FDA |
| Docket | FDA-2009-P-0289 |
| Posted | Jun 29, 2009 |
At a glance
- None Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: